BACKGROUND: Total pancreatectomy (TP) eliminates the risk of postoperative pancreatic fistula (POPF) and its associated secondary complications. Hence, it may theoretically offer advantages over pancreaticoduodenectomy (PD) regarding early postoperative outcome of patients with high-risk pancreatic remnant. METHODS: Ninety-day mortality and morbidity of 100 TP vs. 100 PD for pancreatic head lesions were retrospectively compared. Groups were matched for pancreatic texture, pancreatic duct size, final histology, age, gender and surgeon. Only patients at high risk for POPF due to soft pancreatic texture and small pancreatic duct <3 mm were included. RESULTS: Preoperatively, the TP-group was characterized by poorer general condition, more comorbidities and more pronounced obesity than the PD-group. Postoperatively, overall morbidity was lower after TP (63% vs. 88%, P<0.001) due to less mild complications. Postpancreatectomy hemorrhage rate was lower after TP than after PD (2% vs. 12%, P=0.014). Duration of surgery, hospital stay, major morbidity (30%) and mortality (7% vs. 5%) were the same. POPF was the most common complication after PD with 32%. Emergency completion pancreatectomy was necessary in 10% of PD with a significantly higher mortality compared to elective TP (50% vs. 7%, P=0.001). CONCLUSIONS: TP may reduce severe POPF-associated complications and prevent mortality related to emergency completion pancreatectomy in some elderly, obese and polymorbid patients with high-risk pancreatic remnant. Careful individual selection by an experienced pancreatic surgeon is mandatory. 2021 Gland Surgery. All rights reserved.
BACKGROUND: Total pancreatectomy (TP) eliminates the risk of postoperative pancreatic fistula (POPF) and its associated secondary complications. Hence, it may theoretically offer advantages over pancreaticoduodenectomy (PD) regarding early postoperative outcome of patients with high-risk pancreatic remnant. METHODS: Ninety-day mortality and morbidity of 100 TP vs. 100 PD for pancreatic head lesions were retrospectively compared. Groups were matched for pancreatic texture, pancreatic duct size, final histology, age, gender and surgeon. Only patients at high risk for POPF due to soft pancreatic texture and small pancreatic duct <3 mm were included. RESULTS: Preoperatively, the TP-group was characterized by poorer general condition, more comorbidities and more pronounced obesity than the PD-group. Postoperatively, overall morbidity was lower after TP (63% vs. 88%, P<0.001) due to less mild complications. Postpancreatectomy hemorrhage rate was lower after TP than after PD (2% vs. 12%, P=0.014). Duration of surgery, hospital stay, major morbidity (30%) and mortality (7% vs. 5%) were the same. POPF was the most common complication after PD with 32%. Emergency completion pancreatectomy was necessary in 10% of PD with a significantly higher mortality compared to elective TP (50% vs. 7%, P=0.001). CONCLUSIONS: TP may reduce severe POPF-associated complications and prevent mortality related to emergency completion pancreatectomy in some elderly, obese and polymorbid patients with high-risk pancreatic remnant. Careful individual selection by an experienced pancreatic surgeon is mandatory. 2021 Gland Surgery. All rights reserved.
Authors: Moritz Koch; O James Garden; Robert Padbury; Nuh N Rahbari; Rene Adam; Lorenzo Capussotti; Sheung Tat Fan; Yukihiro Yokoyama; Michael Crawford; Masatoshi Makuuchi; Christopher Christophi; Simon Banting; Mark Brooke-Smith; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yuji Nimura; Joan Figueras; Ronald P DeMatteo; Markus W Büchler; Jürgen Weitz Journal: Surgery Date: 2011-02-12 Impact factor: 3.982
Authors: Marc G Besselink; L Bengt van Rijssen; Claudio Bassi; Christos Dervenis; Marco Montorsi; Mustapha Adham; Horacio J Asbun; Maximillian Bockhorn; Oliver Strobel; Markus W Büchler; Olivier R Busch; Richard M Charnley; Kevin C Conlon; Laureano Fernández-Cruz; Abe Fingerhut; Helmut Friess; Jakob R Izbicki; Keith D Lillemoe; John P Neoptolemos; Michael G Sarr; Shailesh V Shrikhande; Robert Sitarz; Charles M Vollmer; Charles J Yeo; Werner Hartwig; Christopher L Wolfgang; Dirk J Gouma Journal: Surgery Date: 2016-09-28 Impact factor: 3.982
Authors: Melissa M Murphy; William J Knaus; Sing Chau Ng; Joshua S Hill; James T McPhee; Shimul A Shah; Jennifer F Tseng Journal: HPB (Oxford) Date: 2009-09 Impact factor: 3.647
Authors: Baki Topal; Steffen Fieuws; Raymond Aerts; Joseph Weerts; Tom Feryn; Geert Roeyen; Claude Bertrand; Catherine Hubert; Marc Janssens; Jean Closset Journal: Lancet Oncol Date: 2013-05-02 Impact factor: 41.316
Authors: L Scholten; T F Stoop; M Del Chiaro; O R Busch; C van Eijck; I Q Molenaar; J H de Vries; M G Besselink Journal: Br J Surg Date: 2019-09-10 Impact factor: 6.939
Authors: Fiona R Kolbinger; Julia Lambrecht; Stefan Leger; Till Ittermann; Stefanie Speidel; Jürgen Weitz; Ralf-Thorsten Hoffmann; Marius Distler; Jens-Peter Kühn Journal: Sci Rep Date: 2022-03-08 Impact factor: 4.379